• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然免疫反应中的病原体识别

Pathogen recognition in the innate immune response.

作者信息

Kumar Himanshu, Kawai Taro, Akira Shizuo

机构信息

Laboratory of Host Defense, WPI Immunology Frontier Research Center, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan.

出版信息

Biochem J. 2009 Apr 28;420(1):1-16. doi: 10.1042/BJ20090272.

DOI:10.1042/BJ20090272
PMID:19382893
Abstract

Immunity against microbial pathogens primarily depends on the recognition of pathogen components by innate receptors expressed on immune and non-immune cells. Innate receptors are evolutionarily conserved germ-line-encoded proteins and include TLRs (Toll-like receptors), RLRs [RIG-I (retinoic acid-inducible gene-I)-like receptors] and NLRs (Nod-like receptors). These receptors recognize pathogens or pathogen-derived products in different cellular compartments, such as the plasma membrane, the endosomes or the cytoplasm, and induce the expression of cytokines, chemokines and co-stimulatory molecules to eliminate pathogens and instruct pathogen-specific adaptive immune responses. In the present review, we will discuss the recent progress in the study of pathogen recognition by TLRs, RLRs and NLRs and their signalling pathways.

摘要

针对微生物病原体的免疫主要依赖于免疫细胞和非免疫细胞上表达的天然受体对病原体成分的识别。天然受体是进化上保守的种系编码蛋白,包括Toll样受体(TLR)、视黄酸诱导基因I样受体(RLR)和核苷酸结合寡聚化结构域样受体(NLR)。这些受体在不同的细胞区室(如质膜、内体或细胞质)中识别病原体或病原体衍生产物,并诱导细胞因子、趋化因子和共刺激分子的表达,以清除病原体并指导针对病原体的适应性免疫反应。在本综述中,我们将讨论TLR、RLR和NLR介导的病原体识别及其信号通路研究的最新进展。

相似文献

1
Pathogen recognition in the innate immune response.天然免疫反应中的病原体识别
Biochem J. 2009 Apr 28;420(1):1-16. doi: 10.1042/BJ20090272.
2
Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases.天然免疫中的 Toll 样受体 (TLRs)、NOD 样受体 (NLRs) 和 RIG-I 样受体 (RLRs)。TLRs、NLRs 和 RLRs 配体作为造血疾病的免疫治疗药物。
Int J Mol Sci. 2021 Dec 13;22(24):13397. doi: 10.3390/ijms222413397.
3
Innate immune recognition of nucleic acids.核酸的天然免疫识别
Immunol Res. 2009;43(1-3):98-108. doi: 10.1007/s12026-008-8053-x.
4
Mechanisms and pathways of innate immune activation and regulation in health and cancer.健康与癌症中固有免疫激活和调节的机制与途径。
Hum Vaccin Immunother. 2014;10(11):3270-85. doi: 10.4161/21645515.2014.979640.
5
Pathogen sensing in innate immunity.先天免疫中的病原体感应。
Expert Rev Vaccines. 2010 Jan;9(1):19-21. doi: 10.1586/erv.09.141.
6
TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity.Toll样受体、NOD样受体和视黄酸诱导基因I样受体:协同参与固有免疫的病原体传感器三联体
Trends Immunol. 2006 Aug;27(8):352-7. doi: 10.1016/j.it.2006.06.003. Epub 2006 Jun 27.
7
Regulation of antiviral innate immune responses by RIG-I family of RNA helicases.RNA解旋酶RIG-I家族对抗病毒天然免疫反应的调控
Curr Top Microbiol Immunol. 2007;316:193-205. doi: 10.1007/978-3-540-71329-6_10.
8
Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response.Toll样受体、RIG-I样RNA解旋酶与抗病毒天然免疫反应
Immunol Cell Biol. 2007 Aug-Sep;85(6):435-45. doi: 10.1038/sj.icb.7100100. Epub 2007 Jul 31.
9
Sensing viral invasion by RIG-I like receptors.通过视黄酸诱导基因I样受体感知病毒入侵。
Curr Opin Microbiol. 2014 Aug;20:131-8. doi: 10.1016/j.mib.2014.05.011. Epub 2014 Jun 23.
10
Recognition of bacterial infection by innate immune sensors.先天免疫传感器对细菌感染的识别。
Crit Rev Microbiol. 2013 Aug;39(3):229-46. doi: 10.3109/1040841X.2012.706249. Epub 2012 Aug 6.

引用本文的文献

1
White spot syndrome virus immediate-early protein (wsv100) antagonizes the NF-κB pathway to inhibit innate immune response in shrimp.白斑综合征病毒即刻早期蛋白(wsv100)拮抗NF-κB信号通路以抑制对虾的先天免疫反应。
PLoS Pathog. 2025 Jun 12;21(6):e1012828. doi: 10.1371/journal.ppat.1012828. eCollection 2025 Jun.
2
Exosomes in infectious diseases: insights into leishmaniasis pathogenesis, immune modulation, and therapeutic potential.传染病中的外泌体:对利什曼病发病机制、免疫调节及治疗潜力的见解。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):4913-4931. doi: 10.1007/s00210-024-03702-7. Epub 2024 Dec 19.
3
Predicting viral proteins that evade the innate immune system: a machine learning-based immunoinformatics tool.
预测逃避先天免疫系统的病毒蛋白:一种基于机器学习的免疫信息学工具。
BMC Bioinformatics. 2024 Nov 9;25(1):351. doi: 10.1186/s12859-024-05972-7.
4
Immunomodulation in Non-traditional Therapies for Methicillin-resistant Staphylococcus aureus (MRSA) Management.非传统疗法治疗耐甲氧西林金黄色葡萄球菌(MRSA)管理中的免疫调节。
Curr Microbiol. 2024 Sep 6;81(10):346. doi: 10.1007/s00284-024-03875-7.
5
Potential of extracellular vesicles in the pathogenesis, diagnosis and therapy for parasitic diseases.细胞外囊泡在寄生虫病发病机制、诊断及治疗中的潜力
J Extracell Vesicles. 2024 Aug;13(8):e12496. doi: 10.1002/jev2.12496.
6
A synbiotic mixture of M16-V, oligosaccharides and pectin, enhances Short Chain Fatty Acid production and improves lung health in a preclinical model for pulmonary neutrophilia.由M16-V、低聚糖和果胶组成的合生元混合物,在肺部中性粒细胞增多症的临床前模型中可增强短链脂肪酸的产生并改善肺部健康。
Front Nutr. 2024 Jun 28;11:1371064. doi: 10.3389/fnut.2024.1371064. eCollection 2024.
7
Host Factors Modulate Virus-Induced IFN Production via Pattern Recognition Receptors.宿主因子通过模式识别受体调节病毒诱导的干扰素产生。
J Inflamm Res. 2024 Jun 12;17:3737-3752. doi: 10.2147/JIR.S455035. eCollection 2024.
8
The causes and consequences of trained immunity in myeloid cells.髓系细胞中训练免疫的原因和后果。
Front Immunol. 2024 Apr 11;15:1365127. doi: 10.3389/fimmu.2024.1365127. eCollection 2024.
9
Maintenance of persistent transmission of a plant arbovirus in its insect vector mediated by the Toll-Dorsal immune pathway.通过 Toll-Dorsal 免疫途径维持植物虫媒病毒在其昆虫媒介中的持续传播。
Proc Natl Acad Sci U S A. 2024 Apr 2;121(14):e2315982121. doi: 10.1073/pnas.2315982121. Epub 2024 Mar 27.
10
Salmonellosis: An Overview of Epidemiology, Pathogenesis, and Innovative Approaches to Mitigate the Antimicrobial Resistant Infections.沙门氏菌病:流行病学、发病机制及减轻抗菌药物耐药性感染创新方法概述
Antibiotics (Basel). 2024 Jan 13;13(1):76. doi: 10.3390/antibiotics13010076.